Citron Research

Nanox's stock falters after investor report calls its business 'a complete farce'
By Dave Muoio | 04:35 pm | September 16, 2020
Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.